Literature DB >> 17922250

Involvement of nuclear progesterone receptors in the formation of anxiety in female mice.

A Yu Galeeva1, S G Pivina, P Tuohimaa, N E Ordyan.   

Abstract

We report here studies on the delayed effects of exogenous progesterone on the formation of anxiety in female mice. Ovariectomized female mice were given seven days of replacement therapy either with the two main ovarian hormones-progesterone and estradiol benzoate-or with progesterone only; levels of anxiety were measured six hours later in the elevated plus-maze. The role of nuclear progesterone receptors in controlling the level of anxiety was assessed by giving some mice injections of the synthetic progesterone receptor blocker mifepristone 2 h before the last dose of hormones. An immunohistochemical method was used to study changes in the number of nuclear progesterone receptors in different areas of the brains of experimental animals. These studies showed that progesterone has a delayed enhancing effect on anxiety in female mice. The role of nuclear progesterone receptors in forming this behavioral characteristic was supported by a strong correlation between changes in the numbers of progesterone receptor-immunopositive cells in several brain structures and the level of anxiety. Prior blockade of progesterone receptors using mifepristone led to a maximal reduction in the level of anxiety, which was also evidence for a role for the genomic mechanisms of action of progesterone in controlling anxiety in females.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922250     DOI: 10.1007/s11055-007-0090-8

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  29 in total

1.  Assessment of neuroleptic-like properties of progesterone.

Authors:  R Rupprecht; M Koch; A Montkowski; M Lancel; J Faulhaber; J Harting; R Spanagel
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

2.  The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy.

Authors:  M S Smith; M E Freeman; J D Neill
Journal:  Endocrinology       Date:  1975-01       Impact factor: 4.736

3.  Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats.

Authors:  S Mora; N Dussaubat; G Díaz-Véliz
Journal:  Psychoneuroendocrinology       Date:  1996-10       Impact factor: 4.905

4.  [Role of sex steroids in development of anxiety in female mice].

Authors:  A Iu Galeeva; P Tuohimaa; V G Shaliapina
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2001-12

5.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 6.  Non-genomic and genomic effects of steroids on neural activity.

Authors:  B S McEwen
Journal:  Trends Pharmacol Sci       Date:  1991-04       Impact factor: 14.819

7.  Brain neurosteroids during the mouse oestrous cycle.

Authors:  C Corpéchot; B E Collins; M P Carey; A Tsouros; P Robel; J P Fry
Journal:  Brain Res       Date:  1997-08-22       Impact factor: 3.252

Review 8.  Role of progesterone and other neuroactive steroids in anxiety disorders.

Authors:  Jean-Michel Le Mellédo; Glen Baker
Journal:  Expert Rev Neurother       Date:  2004-09       Impact factor: 4.618

Review 9.  Glucocorticoids, depression, and mood disorders: structural remodeling in the brain.

Authors:  Bruce S McEwen
Journal:  Metabolism       Date:  2005-05       Impact factor: 8.694

10.  Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety.

Authors:  A S Russo; F S Guimarães; J C De Aguiar; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more
  3 in total

1.  Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability.

Authors:  Ethan H Beckley; Angela C Scibelli; Deborah A Finn
Journal:  Psychoneuroendocrinology       Date:  2010-12-15       Impact factor: 4.905

Review 2.  Contributions of estrogen receptor-α and estrogen receptor-ß to the regulation of behavior.

Authors:  Marc J Tetel; Donald W Pfaff
Journal:  Biochim Biophys Acta       Date:  2010-01-25

3.  Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats.

Authors:  Valentina Vozella; Bryan Cruz; Luis A Natividad; Federica Benvenuti; Nazzareno Cannella; Scott Edwards; Eric P Zorrilla; Roberto Ciccocioppo; Marisa Roberto
Journal:  Int J Mol Sci       Date:  2021-03-18       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.